Blog Archive

From The Corner Office

Ken VanLuvanee, President & CEO   It was a wonderful 2023 for the team at Facet Life Sciences.  We had some fun, welcomed several new team members into the Facet family, joined hands with several new clients, and advanced s...

Read More
Corner Office Memo

Facet By The Numbers – Q3 2023

FACET BY THE NUMBERS Total submissions to FDA July – Sept 2023:  over 40 (over 3 submissions a week!) Early-stage development highlights: prepared/submitted 2 INDs for new chemical entities and over 30 IND amendments (e.g., new...

Read More

Partner News – Q3 2023

Partner News Facet is delighted to announce a partnership with Veramed.  Veramed is a pioneering CRO redefining intelligent healthcare decision-making.  As trusted industry specialists, Veramed’s global team provides next-level...

Read More

FDA Round Up – Q3 2023

FDA ROUNDUP: FDA Issues New User Fees for 2023-2024 – Costs Are Going Up! If you are submitting an NDA or BLA application that includes clinical data in 2023 or 2024, you will pay $3.24M, and a whopping $4.04M, respectively!  P...

Read More

Did You Know – Q3 2023

DID YOU KNOW? Facet is on a mission to help small organizations bring great science and innovative products to and through FDA. Many small organizations waste significant money and time running large nonclinical programs to su...

Read More
Go to Top